Product correctly added to cart.

discount label
Perindoprilat-d4
View 3D

Biosynth logo

Perindoprilat-d4

CAS: 1356841-18-3

Ref. 3D-GEC84118

1mgTo inquire
5mgTo inquire
10mgTo inquire
25mgTo inquire
Estimated delivery in United States, on Tuesday 2 Jul 2024

Product Information

Name:
Perindoprilat-d4
Description:

Perindoprilat-d4 is a medicinal compound that has been extensively studied for its potential use in cancer treatment. It has been shown to induce apoptosis, or programmed cell death, in a variety of cancer cell lines. Perindoprilat-d4 also inhibits the activity of certain kinases, which are enzymes that play a key role in regulating the cell cycle and promoting cell growth. This inhibition leads to a disruption of the normal cell cycle and ultimately results in cell death. In addition to its anti-cancer properties, Perindoprilat-d4 has also been shown to have potential therapeutic applications in other diseases where kinase inhibitors may be beneficial, such as autoimmune disorders or inflammatory conditions. Its effectiveness has been demonstrated in both human and Chinese hamster ovary cells, making it a promising candidate for further research into novel cancer treatments.

Brand:
Biosynth
Long term storage:
Notes:

Chemical properties

Molecular weight:
344.4 g/mol
Formula:
C17H28N2O5
Purity:
Min. 95%
MDL:
Melting point:
Boiling point:
Flash point:
Density:
Concentration:
EINECS:
Merck:
HS code:

Hazard Info

UN Number:
EQ:
Class:
H Statements:
P Statements:
Forbidden to fly:
Hazard Info:
Packing Group:
LQ:

Technical inquiry about: 3D-GEC84118 Perindoprilat-d4

Please use instead the cart to request a quotation or an order

If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.

* Mandatory fields.
Welcome to CymitQuimica!We use cookies to enhance your visit. We do not include advertising.

Please see our Cookies Policy for more details or adjust your preferences in "Settings".